Geneva v. Marsam

Geneva filed a countersuit against its joint venture partner following the break-down of settlement negotiations, alleging that generics injectables maker Marsam has contacted "existing Geneva/Marsam customers and request[ed] to sell products under the Marsam label during the period that the partners were attempting to resolve matters in dispute" ("The Pink Sheet" Aug. 31, In Brief). In a July 22 lawsuit, Marsam charged that Geneva has "engaged in a secret course of self-dealing at Marsam's expense" ("The Pink Sheet" July 27, T&G 1).